Skip to Main Content

Paper Details

Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT).
Cureus
2
2023
Author NameAffiliation
Simeng SuyMedStar Georgetown University Hospital
Nima AghdamBeth Israel Deaconess Medical Center, Harvard Medical School
Sean P CollinsMedStar Georgetown University Hospital
  • 1 - 3

Datasets

Release 1.2